Skip to main content
Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc. — Investor Relations & Filings

Ticker · HOWL ISIN · US95075A1079 US Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2023-09-18 Investor Presentation
Country US United States of America
Listing US HOWL

About Werewolf Therapeutics, Inc.

https://werewolftx.com/

Werewolf Therapeutics, Inc. is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company utilizes its proprietary PREDATOR® protein engineering platform to create a novel class of conditionally activated proinflammatory immune modulators, known as INDUKINE™ and INDUCER™ molecules. These therapies are designed to be delivered systemically in an inactive state and become selectively activated within the tumor microenvironment. This approach aims to generate a potent, localized anti-tumor immune response while minimizing the systemic side effects associated with conventional immunotherapies. The company's pipeline includes clinical-stage candidates such as WTX-124 and WTX-330.

Recent filings

Filing Released Lang Actions
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated September 18, 2023. It announces the public availability of an updated corporate slide presentation on the company's website and includes the slide presentation as Exhibit 99.1. The text explicitly states that the slide presentation is furnished as an exhibit and is incorporated by reference, and the document itself is short (3473 characters). There are no financial statements or detailed financial data included, only a disclosure of the presentation availability. According to the 'Menu vs Meal' rule, this is an announcement of a report (the presentation), not the report itself. The nature of the exhibit (corporate slide presentation) aligns with an Investor Presentation. Therefore, the document is best classified as an Investor Presentation (IP).
2023-09-18 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report under the Securities Exchange Act of 1934. It specifically states that the company issued a press release announcing financial results for the quarter ended June 30, 2023, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The document length is 3782 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document is best classified as an Earnings Release (ER) since it announces quarterly financial results highlights via a press release attached as an exhibit.
2023-08-10 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-10 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 21, 2023. It reports amendments to the company's bylaws and the results of the annual stockholder vote on director elections and auditor ratification. The content focuses on governance changes and voting results rather than full financial statements or earnings. The presence of voting results and bylaws amendments indicates this is primarily a Declaration of Voting Results & Voting Rights Announcement. The document is over 6,000 characters and contains detailed voting outcomes, not just a brief announcement or a proxy solicitation. Therefore, the best classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2023-06-27 English
OWNERSHIP DOCUMENT
Director's Dealing
2023-06-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.